Mayflower Financial Advisors, LLC Inovio Pharmaceuticals, Inc. Transaction History

Mayflower Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$1.41 - $2.5 $43,643 - $77,382	30,953 New	30,953 $0
Q3 2022 Oct 19, 2022	BUY	$1.66 - $2.79 $51,381 - $86,358	30,953 New	30,953 $53,000
Q1 2022 Apr 21, 2022	BUY	$2.97 - $5.2 $1,202 - $2,106	405 Added 1.33%	30,953 $111,000
Q4 2021 Jan 21, 2022	SELL	$4.99 - $7.46 $1,467 - $2,193	-294 Reduced 0.95%	30,548 $152,000
Q2 2021 Jul 29, 2021	BUY	$6.23 - $10.03 $2,741 - $4,413	440 Added 1.45%	30,842 $286,000
Q1 2021 Apr 23, 2021	BUY	$8.81 - $16.96 $11,682 - $22,488	1,326 Added 4.56%	30,402 $282,000
Q4 2020 Apr 12, 2021	BUY	$8.5 - $12.85 $247,146 - $373,626	29,076 New	29,076 $257,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.